Clinician's Roundtable

Host: Raj Chovatiya, MD, PhD Guest: Jason E. Hawkes, MD, MS, FAAD Roflumilast and tapinarof are two of the new topical nonsteroidal therapies for plaque psoriasis that have several advantages over the traditional topical steroids. Learn more about how emerging topical nonsteroidals could impact your patients with plaque psoriasis with Dr. Raj Chovatiya and Dr. Jason Hawkes, a medical dermatologist in the Greater Sacramento area who also sits on the National Psoriasis Foundation Medical Board and Scientific Advisory Committee.

Host: Mary Katherine Cheeley, PharmD, BCPS, CLS, FNLA Guest: Dylan Baker, MD Georgia has the highest rate of new HIV diagnoses out of any state in the country, and so it’s imperative that we make this medication more accessible now in order to save future generations from living with HIV. To dive further into the benefits and challenges of this program, Dr. Mary Katherine Cheeley is joined by Dr. Dylan Baker, Assistant Professor of Medicine at Emory University and the Associate Medical Director of the Grady PrEP Clinic.

Host: Charles Turck, PharmD, BCPS, BCCCP Guest: Sorana Segal-Maurer, MD Research has shown that those living with HIV are more likely to be malnourished and experience nutrient deficiencies that play an essential role in their immunity. In the early days of HIV, a typical recommendation was to increase a patient’s calorie count. To discuss how the focus on nutrition has changed now that this patient population is living much longer, Dr. Charles Turck is joined by Dr. Sorana Segal-Maurer, Director of Infectious Diseases at New York-Presbyterian Queens and Professor of Clinical Medicine at Weill Cornell Medicine in New York City.

Host: Charles Turck, PharmD, BCPS, BCCCP Guest: Sorana Segal-Maurer, MD For most patients living with HIV, antiretroviral therapy is extremely effective. However, HIV mutates with frequency, allowing it to become resistant to antiviral medication. To discuss how we can effectively treat these patients, Dr. Charles Turck is joined by Dr. Sorana Segal-Maurer, Director of Infectious Diseases at New York-Presbyterian Queens and Professor of Clinical Medicine at Weill Cornell Medicine in New York City.

Host: Mary Katherine Cheeley, PharmD, BCPS, CLS, FNLA Guest: Sarah Bauerle Bass, PhD, MPH, FSBM Although the rate of new HIV diagnoses in the United States is steadily declining, people in prisons are still disproportionately living with the virus, which is why researchers at Temple University are now developing an app aimed at improving HIV prevention and substance use treatment access for incarcerated women in Philadelphia. To learn more about this research, Dr. Mary Katherine Cheeley is joined by Dr. Sarah Bauerle Bass, Associate Professor of Social and Behavioral Sciences and the Director of Risk Communication Laboratory at Temple University.

Host: Charles Turck, PharmD, BCPS, BCCCP Guest: Kamel Khalili, PhD Scientists at Temple University’s Lewis Katz School of Medicine have identified a novel gene-editing strategy aimed at eliminating HIV-1 infection with no adverse effects on cell mortality. Find out how this recent discovery could get us one step closer to a cure for HIV with Dr. Charles Turck and Dr. Kamel Khalili, the Laura H. Carnell Professor in the Department of Neuroscience and Chair of the Department of Microbiology, Immunology & Inflammation.

Host: Michael Greenberg, MD Guest: William E. Hauter, MD Illinois lawmakers are taking steps to end intrusive mental health questionnaires for physician licensures. To learn more about Illinois House Bill 3109 and how you can get involved, join Dr. Michael Greenberg as he sits down with Dr. Bill Hauter, Illinois State Representative and Anesthesiologist.

Host: Mario R. Nacinovich, Jr., MSc Guest: Sally L. Baxter, MD, MSc The All of Us Research Program discovered associations between socioeconomic factors and visit adherence among patients with glaucoma. Can clinicians use this data to improve visit adherence? Mario Nacinovich joins Dr. Sally Baxter, an Assistant Professor of Ophthalmology and Biomedical Informatics at the University of California-San Diego, to take a look at this data.

Host: Charles Turck, PharmD, BCPS, BCCCP Guest: Gates B. Colbert, MD When managing a rare disease like IgA nephropathy (IgAN), it’s essential to keep each individual patient at the center of it all, and this type of approach starts at the diagnostic stage. Joining Dr. Charles Turck to share strategies for providing patient-centered care throughout every step of the journey is Dr. Gates Colbert, Assistant Clinical Professor at Texas A&M College of Medicine. var _ss = _ss || []; _ss.push(['_setDomain', 'https://koi-3S29M6OVIS.marketingautomation.services/net']); _ss.push(['_setAccount', 'KOI-1FZ71YMSRUCN8I']); _ss.push(['_trackPageView']); window._pa = window._pa || {}; // _pa.orderId = "myOrderId"; // OPTIONAL: attach unique conversion identifier to conversions // _pa.revenue = "19.99"; // OPTIONAL: attach dynamic purchase values to conversions // _pa.productId = "myProductId"; // OPTIONAL: Include product ID for use with dynamic ads (function() { var ss = document.createElement('script');

Host: Charles Turck, PharmD, BCPS, BCCCP Guest: Carl P. Walther, MD The alternative complement pathway and the lectin pathway are the two pathways that are important in IgA nephropathy (IgAN). So how does the dysregulation of these two pathways impact disease progression, and how might this knowledge help us optimize our approach to treating patients with IgAN? Joining Dr. Charles Turck to answer those and other key questions is nephrology specialist Dr. Carl Walther.

Host: Frank Cortazar, MD Have you ever heard or thought that IgA nephropathy (IgAN) is only a short-term disease? Or that it’s benign? These are just some of the many common misconceptions surrounding IgAN, which is why Dr. Frank Cortazar from the New York Nephrology Vasculitis and Glomerular Center is here to help debunk these and other prevalent myths.

Host: Frank Cortazar, MD There are several challenges associated with the management of glomerular diseases like IgA nephropathy and C3 glomerulopathy. But in order to overcome those challenges, we must first have a firm understanding of them. That’s why Dr. Frank Cortazar from the New York Nephrology Vasculitis and Glomerular Center is here to break down those common challenges so we can work to better manage IgA nephropathy and C3 glomerulopathy.

Host: Mario R. Nacinovich, Jr., MSc Guest: Sally L. Baxter, MD, MSc The All of Us Research Program discovered how socioeconomic factors such as lower income and education levels were associated with lower odds of seeing an eye doctor. Mario Nacinovich joins Dr. Sally Baxter, an Assistant Professor of Ophthalmology and Biomedical Informatics at the University of California-San Diego, to explore how socioeconomic factors could impact care for patients with glaucoma.

Host: John Russell, MD Guest: Stanton Miller, MD, MPH, FACS Patients who live in an environment impacted by gun violence may face lifelong challenges. But addressing gun violence from a public health standpoint may help clinicians manage the biological, behavioral, and social aspects of this disease. Dr. John Russell is joined by Dr. Stan Miller from the Jefferson Center for Injury Research & Prevention to discuss how clinicians can reframe their approach.

Host: Charles Turck, PharmD, BCPS, BCCCP Guest: Andrew Clark, MD Emerging treatment options have helped patients with HIV live longer, but the aging population faces its own unique challenges. To explore how we can combat these challenges—including the ongoing stigma around HIV—Dr. Charles Turck is joined by Dr. Andrew Clark, who is the Global Medical Lead at ViiV Healthcare.

Host: Charles Turck, PharmD, BCPS, BCCCP Guest: W. Frank Peacock, MD For patients with opioid-induced constipation (OIC), can Narcan play a role in finding a new treatment option? Dr. Charles Turck is joined by Dr. Frank Peacock from the Baylor College of Medicine to explore key data on the role of methylnaltrexone in the treatment of OIC.

Host: Peter Buch, MD, FACG, AGAF, FACP Guest: Wendy Wright, DNP, FNP-BC, ANP-BC, FAANP, FAAN, FNAP Physicians and advanced practice registered nurses (APRNs) may practice differently but they can still get their patient to the same outcome. So where do the conflicts arise? Join Dr. Peter Buch as he walks us through this with Dr. Wendy Wright, nurse practitioner and founder of Wright & Associates Family Healthcare.

Host: Mario R. Nacinovich, Jr., MSc Guest: Walter Koroshetz, MD Amyotrophic lateral sclerosis (ALS) is a rare neurogenerative disease, and organizations including the FDA and NIH are working to accelerate potential therapies. What’s on the horizon for the treatment landscape? Mario Nacinovich joins Dr. Walter Koroshetz, who is the Director of the National Institute of Neurological Disorders and Stroke, to explore these new developments.

Host: Mario R. Nacinovich, Jr., MSc Guest: Richard Kojan, MD As the fight against Ebola continues, can a new biosecure emergency care unit (CUBE) and therapeutic guidelines from the World Health Organization (WHO) help combat this disease? Mario Nacinovich joins study Dr. Richard Kojan, President of the Alliance for International Medical Action, to discuss these new guidelines.

Host: Mario R. Nacinovich, Jr., MSc Guest: Charles P. Gerba, MD A recent case of polio emerging in New York City have clinicians questioning whether or not we need to be concerned about a spread. What do we need to know about this case—and our potential risk—of polio? Joining Mario Nacinovich to take a look at this case is microbiologist Dr. Charles Gerba, a Professor of Environmental Science at the University of Arizona.